Backed by Science. Built for Patients.
Clinical Trial Evidence
At mBIOTA Labs, we create clinically proven medical foods for patients with GI disorders - combining scientific rigor with empathy and respect for the patient experience.
2023 Prospective Clinical Study
As published in Clinical Gastroenterology and Hepatology
Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients with Intestinal Microbial Overgrowth
Our 2023 clinical trial of a 2-week course of mBIOTA in SIBO and IMO patients. The mBIOTA Elemental diet was tolerated by 100% of patients, eradicated overgrowth in 73% of patients overall and provided adequate relief from symptoms in 83% of patients.
CLINICALLY PROVEN FOR SIBO AND IMO¹
In a Cedars-Sinai clinical study, the mBIOTA Elemental diet eradicated SIBO in 83% of patients.
A 2023 clinical trial at Cedars-Sinai in Los Angeles evaluated the mBIOTA Elemental Diet and demonstrated consistent eradication outcomes across patients with SIBO, IMO, or both.
Clinical Eradication Rates by Patient Cohort
Based on normalization of patient’s lactulose breath test after day 14 of exclusive elemental diet.
These findings support hundreds of other clinical studies (across five decades) that have also found that elemental diets can relieve symptoms of GI conditions like IMO and SIBO.²
CLINICAL RESULTS
Participants reported up to an 82% reduction in 12 common GI symptoms.
Over the past 50 years, hundreds of clinical studies have shown that Elemental Diets help reduce symptoms of chronic GI conditions, including IBS and SIBO.²
In the 2023 clinical trial at Cedars-Sinai in Los Angeles, 83% of patients who completed two weeks of an exclusive elemental diet reported symptom relief that continued to improve even two weeks after diet completion.
Symptom Reduction after mBIOTA Elemental
Published Research Using Elemental Diets .
Clinical Gastroenterology and Hepatology
Effect, Tolerability, and Safety of Exclusive mBIOTA Elemental Diet in Patients with Intestinal Microbial Overgrowth
Digestive Diseases and Sciences
Elemental Diet as a Therapeutic Modality: A Comprehensive Review
American College of Gastroenterology 2025
mBIOTA Elemental Diet Achieves Deep Remission in Dupilumab-Responsive EoE
Digestive Diseases & Sciences
Comparing Elemental Diet and Steroid Treatment in Crohn's Disease
Digestive Diseases & Sciences
mBIOTA Elemental Leads to Successful Outpatient Management of Partial Small Bowel Obstruction
American College of Gastroenterology 2025
mBIOTA Elemental Diet Does Not Promote Fungal Overgrowth and Reduce Candida
American College of Gastroenterology 2025
mBIOTA Elemental Diet Enables Outpatient Resolution of Partial Small Bowel Obstruction
American College of Gastroenterology 2025
Palatable mBIOTA Elemental Diet Reduces Visceral Fat Through Microbial and Hormonal Shifts
Digestive Disease Week 2025
Reduction of Methane Levels Correlates with Fecal Abundance of M. smithii
FNM 2024
Maintained Visceral and Total Body Fat Loss Following mBIOTA Elemental Diet
American College of Gastroenterology 2024
Achieving Organoleptic Acceptability with mBIOTA Elemental Formula
Digestive Disease Week 2024
Compliance, Safety, and Effect of Exclusive Palatable mBIOTA Elemental Diet in Microbial Overgrowth
